Sir -The impact of menstrual cycle-dependent timing of surgery on long-term outcome of breast cancer patients has been discussed intensively in this forum by Holli et al. (1995) designed a simulation study using randomly generated exponentially distributed survival data. We randomly assigned a menstrual cycle value between 1 and 28 days to every survival time. We varied the sample size (n = 140, n = 280, n = 1400), the amount of censoring (33% and 67%) and the minimum selection interval (between 7 days and 14 days). When using minimum lengths of the selection interval ranging from 7 days to 14 days, a total of 210 different partitions were possible. We generated 2000 simulated samples for each of these 210 scenarios.
Neither the sample size nor the amount of censoring had any remarkable influence on the inflation of type I error rate (Figure la and b) . Choosing a selection interval of 14 days yielded a type I error rate of about 27% at the common 5% nominal level. In other words, there were significant results in one out of four cases, although there was nothing to detect according to the design of this simulation study. At a nominal level of 10% and 1% the false-positive rates were 47% and 7.3% respectively (Figure lb) . The multiple testing problem became more evident allowing a minimum selection interval ranging from 7 to 14 days. The type I error rate increased to 63% at a nominal level of 5%. Even if we used the 'impressive' 1% nominal level, we obtained a significant result in 25% of the tests (Figure la) . The simulation study showed that for achieving an actual type I error rate (significance level) of approximately 5%, a P-value<0.006 was necessary, using a selection interval of 14 days. This barrier dropped to a P-value <0.001, when we used minimum selection intervals ranging from 7 days to 14 days.
In our patient sample (n = 149), we obtained statistically significant results regarding disease-free and overall survival using a multiple testing approach for a minimum selection interval ranging from 7 days to 14 days (smallest P-value found: 0.011). After correction for type I error using the according quantiles of the distribution of the minimum Pvalue in the 2000 simulated samples, these previously significant results failed to achieve significance (an uncorrected P-value of 0.011 corresponds to a corrected one of 0.27).
In view of the data described above and the works of Sample size Figure 1 Effect of the minimum P-value approach on the falsepositive rate for selection intervals between 7 days and 14 days (a) and for a selection interval of 14 days (b). The nominal levels shown are 10%, 5% and 1%. Each plotted point was obtained from 2000 simulated samples based on there being no relation between the menstrual phase and survival, with 33% censoring (-) and 67% censoring (-- 
